Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

NCT04840264 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Peritoneal Carcinomatosis

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin
DRUG: Fluorouracil

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University